Morley Stephanie 4/A
4/A · Zomedica Pharmaceuticals Corp. · Filed Apr 17, 2018
Insider Transaction Report
Form 4/AAmended
Morley Stephanie
COO & VP of Product Dev
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2018-03-29−500,000→ 0 totalExercise: $2.20From: 2017-08-14Exp: 2019-08-14→ Common Shares, without par value (500,000 underlying) - Exercise/Conversion
Common Shares, without par value
2018-03-29$2.20/sh+500,000$1,100,000→ 1,355,580 total
Footnotes (2)
- [F1]This amendment is being filed to correctly state the stock options that were exercised. The options that were exercised were misstated on Stephanie Morley's ("Reporting Person") original Form 4 filed with the Securities Exchange Commission on March 30, 2018. Reporting Person exercised 500,000 options at an exercise price of $2.20 per share. Reporting Person continues to hold 1,100,000 options exercisable at $0.20 per share which were granted on March 28, 2016.
- [F2]The options vested upon grant. The option is currently fully vested.